Jilin Aodong Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China. The company provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in the highway construction and toll collection businesses; animal husbandry activities; manufacture of specialty chemicals; production and supply of heat and water; wholesale, retail, and distribution of medicines; production and sale of packaging materials; and information consulting and advertising design and production activities. In addition, the company offers pharmaceutical excipients and packaging materials; produces and sells enzyme stock solutions; ginseng and antler products; sells health care products; and processes edible agricultural products, etc. Further, it provides products in cardiovascular; women and children medication; liver, gallbladder, and stomach; antipyretic and analgesic; rheumatic bone disease; antibacterial and anti-inflammatory; relieve cough and reduce phlegm; and urinary medication therapeutic areas, as well as medical devices, health foods, and others. Jilin Aodong Pharmaceutical Group Co., Ltd. was founded in 1957 and is headquartered in Dunhua, China.
Metrics to compare | 000623 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship000623PeersSector | |
---|---|---|---|---|
P/E Ratio | 11.1x | 28.6x | −0.5x | |
PEG Ratio | 0.17 | −0.98 | 0.00 | |
Price/Book | 0.7x | 2.9x | 2.6x | |
Price / LTM Sales | 9.0x | 4.1x | 3.2x | |
Upside (Analyst Target) | - | 13.1% | 45.3% | |
Fair Value Upside | Unlock | 11.4% | 7.4% | Unlock |